Skip to main content

Table 2 Logistic regression models displaying associations of Galectin-4 levels and probability of being HO

From: Galectin-4 levels in hospitalized versus non-hospitalized subjects with obesity: the Malmö Preventive Project

 

HO (n = 407) vs. NHO (n = 110)

OR (CI95%)

p

Unadjusted

  

 Galectin-4

2.03 (1.42–2.90)

< 0.001

Model 1

  

 Galectin-4

1.85 (1.28–2.67)

0.001

 Age

1.05 (1.01–1.09)

0.013

 Sex

0.93 (0.56–1.53)

0.765

Model 2

  

 Galectin-4

1.72 (1.16–2.54)

0.007

 Age

1.05 (1.00–1.09)

0.030

 Sex

0.73 (0.42–1.25)

0.246

 Diabetes

0.60 (0.33–1.10)

0.098

 Total cholesterol

0.71 (0.56–0.86)

< 0.001

 Smoking

1.34 (0.67–2.65)

0.407

 Hypertension

1.03 (0.50–2.11)

0.938

 BMI

1.00 (0.93–1.07)

0.885

 FPG

1.27 (0.92–1.75)

0.140

  1. Values are odds ratios (OR) and 95% confidence intervals. Bold values denote statistical significance at the p<0.05
  2. BMI body mass index, FPG fasting plasma glucose, HO hospitalized subjects with obesity